menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

MabVax Therapeutics Holdings, I (MBVX)
0.82 0.05 (6.52%)  11-24 12:59
Open: 0.7698 Prev Close: 0.7698
High: 0.82 Low: 0.75
Volume: 508,965 Market Cap: 17M
Year High: 4.25 Year Low: 0.43
Stock Technical Analysis
Overall       
Targets Six months: 2.2625    One year: 2.6864
Supports Support1: 1.3500   Support2: 1.1232
Resistances Resistance1: 1.9371    Resistance2: 2.3000 
Pivot Point 1.4612 
Moving Averages MA(5): 1.4300      MA(20): 1.5009 

MA(100): 2.1344  -1     MA(250): 3.3112 
MACD MACD(12,26): -0.092      Signal(12,26,9): -0.100 
Stochastic Oscillator %K(14,3): 16.667      %D(3): 20.556 
RSI RSI(14): 37.998 
52-Week High: 6.0500  Low: 1.3500  Change(%): -68
Average Volume(K) 3-Month: 82  10-Days: 67
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is below its mid-term; and below long term moving averages. From the relationship between price and moving averages; we can see that: this stock is BEARISH in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed above bottom band by 16.4%; Bollinger Bands are 59.2% narrower than normal.The narrow width of the bands suggests low volatility as compared to MBVX's normal range. The bands have been in this narrow range for 4 bars. This is often a sign that a market may be about to initiate a new trend.

Stoxline

Stock Chart

Top 100 stocks

Stock News
MabVax Therapeutics Holdings, Inc. Provides Corporate Overview and Business ...
Tue, 17 Oct 2017 11:16:25 GMT

MabVax Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders ...
Thu, 16 Nov 2017 12:00:00 GMT

MabVax Therapeutics Holdings, Inc. Announces $500000 Registered Direct Offering
Wed, 11 Oct 2017 11:48:45 GMT

MabVax Therapeutics Holdings, Inc. Announces $1.25 Million Registered Direct ...
Fri, 22 Sep 2017 19:30:00 GMT

MabVax Therapeutics Holdings Inc.
Sat, 11 Oct 2014 22:22:54 GMT

MabVax Therapeutics Announces Uplisting to The Nasdaq Capital Market and $8 ...
Wed, 17 Aug 2016 12:00:00 GMT

MabVax Therapeutics to Present Positive Development Study Results Enabling ...
Mon, 13 Nov 2017 12:22:30 GMT

MabVax Therapeutics Announces FDA Authorization to Proceed with MVT-1075 in a ...
Thu, 23 Feb 2017 13:32:09 GMT

MabVax Therapeutics Engages Greenhill & Co. as Advisor for Exploring Strategic ...
Wed, 06 Sep 2017 12:00:00 GMT

MabVax Therapeutics Holdings, Inc. Has a Promising Pancreatic Cancer Treatment
Mon, 17 Oct 2016 17:15:00 GMT